相关实验视频
Updated: Jul 24, 2025

07:45
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
53.3K
一个罕见的Regorafenib诱导的ST-升高心肌梗塞病例
Sadichhya Karki1, Vaishali Deenadayalan1, Prajwal Shrestha1
1Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.
Cureus
|July 3, 2023
概括
用于转移性结直肠癌的雷戈拉费尼布很少会导致心肌梗塞 (心脏病发作). 本病例报告详细介绍了一名患有ST升高心肌梗塞 (STEMI) 的患者,这是regorafenib的异常不良影响.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 雷戈拉菲尼布是治疗转移性结直肠癌的口服多酶抑制剂.
- 多酶抑制剂与心脏副作用有关,主要是高血压.
- 心肌缺血是regorafenib的一个非常罕见的不良反应.
研究的目的:
- 报告一种极为罕见的ST升高心肌梗塞 (STEMI) 病例,该病例是由regorafenib引起的.
- 为了突出regorafenib在癌症患者中的潜在心脏毒性.
主要方法:
- 一个74岁的男性患者的病例报告,患有IVa期结肠癌.
- 患者正在第二轮Regorafenib治疗中.
- 评估包括评估急性胸痛和左心导管.
主要成果:
- 患者出现了急性发作,间歇性,非强迫性胸痛,辐射到背部.
- 左心导管检查显示没有动脉样硬化病变.
- ST升高心肌梗塞 (STEMI) 被归因于regorafenib的极为罕见的不良事件.
结论:
- 雷戈拉菲尼布可以诱导ST升高心肌梗塞 (STEMI),这是一个罕见的不良事件.
- 临床医生应警在接受regorafenib治疗的患者心脏并发症.
- 这一案例强调了在癌症患者出现胸痛时考虑药物诱导的心肌损伤的重要性.
相关概念视频
Acute Coronary Syndrome I: Introduction
32
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
32
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
21
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
21
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
203
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
203

